Cutler Group LP Iveric Bio, Inc. Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	SELL	$18.67 - $24.56 $13,069 - $17,192	-700 Reduced 70.0%	300 $7,000
Q4 2022 Feb 07, 2023	SELL	$17.24 - $23.95 $42,789 - $59,443	-2,482 Reduced 71.28%	1,000 $21,000
Q3 2022 Oct 25, 2022	BUY	$9.4 - $18.59 $32,730 - $64,730	3,482 New	3,482 $62,000
Q4 2021 Jan 18, 2022	BUY	$13.83 - $18.78 $8,298 - $11,268	600 New	600 $10,000
Q4 2020 Jan 21, 2021	SELL	$5.65 - $7.66 $1,130 - $1,532	-200 Closed	0 $0
Q3 2020 Oct 27, 2020	SELL	$4.01 - $6.29 $6,416 - $10,064	-1,600 Reduced 88.89%	200 $1,000
Q2 2019 Aug 09, 2019	BUY	$1.21 - $1.48 $2,178 - $2,664	1,800 New	1,800 $2,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.